| Market Cap | $6.54B | |
| Enterprise Value | $4.78B | |
| Revenue | $77.7M | +39183.1% |
| Gross Profit | — | — |
| EBITDA | -$747.9M | — |
| Net Income | -$957.4M | — |
| Diluted EPS | -$1.13 | — |
| Free Cash Flow | -$660.2M | — |
| DPS (FY2025) | $0.00 |
| Trailing yield | 0.00% |
| Payout ratio | — |
| Growth streak | 0 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | $0.00 | — | reported |
| FY20242024-12-31 | $0.00 | — | reported |
| FY20232023-12-31 | $0.00 | — | reported |
| FY20222022-12-31 | $0.00 | — | reported |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 6y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Operating Margin | — | — | — | −45745.54% | −438789.71% | −1346.92% | 83% | 2% | |
| EBITDA Margin | — | — | — | −42790.79% | −412633.82% | −1271.75% | 83% | 2% | |
| NOPAT Margin | — | — | — | −36138.98% | −346643.87% | −1064.07% | 83% | 1% | |
| Net Margin | — | — | — | −49714.15% | −447083.82% | −1740.46% | 83% | 2% | |
| FCF Margin | — | — | — | −33374.81% | −350650.00% | −1055.33% | 83% | 2% | |
| OCF Margin | — | — | — | −30409.98% | −320784.56% | −954.41% | 83% | 2% | |
| Capex Intensity | — | — | — | 2964.83% | 29865.44% | 100.92% | 17% | 98% | |
| ▸Returns on Capital · 3 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 2 ratios | |||||||||
| ▸Earnings quality · 1 ratios | |||||||||
| ▸Liquidity & coverage · 5 ratios | |||||||||
| ▸Leverage · 2 ratios | |||||||||
| ▸Working capital · 1 ratios | |||||||||
| ▸Per share · 6 ratios | |||||||||
| Line | 2020↗ | 2021↗ | 2022↗ | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|---|---|---|
| Revenue | — | $0 | $0 | $1.0M | $136,000 | $53.4M |
| YoY % | -86.8% | +39183.1% | ||||
| R&D Expense | $108.7M | $197.6M | $296.3M | $367.0M | $477.2M | $581.1M |
| YoY % | +81.7% | +50.0% | +23.9% | +30.0% | +21.8% | |
| SG&A Expense | $23.5M | $61.5M | $95.9M | $105.9M | $119.7M | $162.6M |
| YoY % | +161.8% | +55.9% | +10.4% | +13.0% | +35.9% | |
| Total Operating Expenses | $132.2M | $259.1M | $392.2M | $473.1M | $596.9M | $773.0M |
| YoY % | +95.9% | +51.4% | +20.6% | +26.2% | +29.5% | |
| Operating Income | -$132.2M | -$259.1M | -$392.2M | -$472.1M | -$596.8M | -$719.6M |
| Interest Expense | $249,000 | $2.4M | $118,000 | — | — | — |
| YoY % | +874.3% | -95.1% | ||||
| Interest & Investment Income | $5.6M | $1.1M | $16.8M | $45.6M | $42.8M | $43.2M |
| YoY % | -79.7% | +1362.3% | +171.4% | -6.0% | +0.8% | |
| Other Non-Operating Income | $18.1M | $68.2M | $134.3M | -$40.8M | -$11.2M | -$208.9M |
| YoY % | +276.9% | +96.8% | ||||
| Equity Method Income | $5.8M | $29.4M | $19.5M | $0 | $0 | — |
| YoY % | +407.1% | -33.8% | -100.0% | |||
| Impairment of Real Estate | $0 | $0 | $0 | $0 | $0 | $0 |
| Pretax Income | -$114.1M | -$190.9M | -$258.0M | -$512.9M | -$607.9M | -$928.5M |
| Income Tax | $31,000 | -$10.5M | $92,000 | $139,000 | $129,000 | $1.3M |
| YoY % | +51.1% | -7.2% | +913.2% | |||
| Net Income (incl. NCI) | -$114.2M | -$180.3M | -$258.0M | — | — | — |
| Net Income | -$114.2M | -$180.3M | -$258.0M | -$513.0M | -$608.0M | -$929.8M |
| Net Income to Common | -$114.2M | -$180.3M | -$258.0M | -$513.0M | -$608.0M | -$929.8M |
| EPS (Basic) | -$1.10 | -$0.61 | -$0.44 | -$0.79 | -$0.87 | -$1.13 |
| EPS (Diluted) | -$1.10 | -$0.61 | -$0.44 | -$0.79 | -$0.87 | -$1.13 |
| Weighted Avg Shares (Basic) | 103.9M | 294.9M | 585.5M | 647.9M | 699.8M | 826.2M |
| YoY % | +183.7% | +98.6% | +10.7% | +8.0% | +18.1% | |
| Weighted Avg Shares (Diluted) | 103.9M | 294.9M | 585.5M | 647.9M | 699.8M | 826.2M |
| YoY % | +183.7% | +98.6% | +10.7% | +8.0% | +18.1% | |
| Dividends Declared per Share | $0 | $0 | $0 | $0 | $0 | $0 |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
